Filing Details

Accession Number:
0000200406-13-000088
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-29 17:51:54
Reporting Period:
2013-07-25
Filing Date:
2013-07-29
Accepted Time:
2013-07-29 17:51:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559387 Paulus Stoffels Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick NJ 08933
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-25 24,000 $66.18 33,073 No 4 M Direct
Common Stock Disposition 2013-07-25 20,540 $92.40 12,533 No 4 S Direct
Common Stock Acquisiton 2013-07-25 29,168 $65.62 41,701 No 4 M Direct
Common Stock Disposition 2013-07-25 24,900 $92.40 16,801 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-07-25 24,000 $0.00 24,000 $66.18
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-07-25 29,168 $0.00 29,168 $65.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-02-15 2015-02-13 No 4 M Direct
0 2010-02-13 2017-02-10 No 4 M Direct
Footnotes
  1. 218 shares held under Issuer's Dividend Reinvestment Plan.
  2. Shares sold to cover exercise price and taxes owed upon exercise of option.
  3. This transaction was executed in multiple trades at prices ranging from $92.39 to $92.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide unpon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. Awarded under Issuer's Stock Option Plan and exercisable in full starting one day after the third anniversary of the grant.